ACS Applied Materials & Interfaces · 2023 · 35 citations · 13 references
PharmacyCancer BiologyOncologyNanomaterialsTheranosticsTumor MicroenvironmentCancer NanomedicineCancer TheranosticsNanomedicineNanoparticle DesignTheranostic ApproachesTheranostic NanoparticlesCancer NanotherapyComputer TomographyMagnetic ResonanceTheranostic AgentsTheranostic NanomaterialsTheranostic NanomedicineTheranostic PlatformsTumor Microenvironment Responsiveness
Nanozymes have brought enormous opportunities for disease theranostics. Here, a self-enhanced catalytic nanocrystal based on a bismuth–manganese core–shell nanoflower containing glucose oxide (GOx), termed BDS-GOx@MnO x, was designed for 4T1 tumor theranostics in vitro and in vivo . The BDS-GOx@MnO x nanozymes enable enhanced starvation treatment (ST) and chemotherapy (CDT) with high efficacy and exhibit sensitive tumor microenvironment (TME) responsive character for tumor therapy as well as for tumor-enhanced computer tomography (CT) and magnetic resonance (MR) diagnostic imaging. The characters and mechanism of the BDS-GOx@MnO x nanozymes have also been systematically studied and revealed.
13
Tumor microenvironment-responsive intelligent nanoplatforms for cancer theranostics
Fei Gong, Nailin Yang, Xianwen Wang et al. · Nano Today · 2020 · 360 citations
Pharmacy, Cancer Biology, Oncology +14
Weiwei Ying, Yang Zhang, Wei Gao et al. · ACS Nano · 2020 · 171 citations
Medicine, Cancer Biology, Oncology +17